Game Plan Financial Advisors »

Regeneron Pharmaceuticals shares owned by Game Plan Financial Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Game Plan Financial Advisors from 13F filings

Historical chart of Game Plan Financial Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Game Plan Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Game Plan Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $111k 115 962.49
2023-12-31 $101k 115 878.29

More positions owned by Game Plan Financial Advisors

Alphabet Inc Class C cs (GOOG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Us Large Cap Growth Etf Uie (SCHG)
Microsoft Corporation (MSFT)
Us Treasury Bill24u S T Bill Due 05/07/24 Bil (Principal)
Us Treasury Bill24u S T Bill Due 04/25/24 Bil (Principal)
Schwab Us Large Cap Value Etf Uie (SCHV)
RPM International (RPM)
Schwab Value Advantage Money Investor Shares MMN (SWVXX)
Select Str Financial Select Spdr Etf Uie (XLF)
Eaton Corp Plc F Fgo (ETN)
Costco Wholesale Corporation (COST)
Schwab Us Small Cap Etf Uie (SCHA)

View all positions for Game Plan Financial Advisors

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals